NexEos Diagnostics, Inc. — Form D
NexEos Diagnostics, Inc. of CHESTER SPRINGS, PA, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-15. The offering totals $5.1M, of which $5.1M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-02-15
- Form: D
- Accession: 0001783828-23-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.1M
- Amount sold: $5.1M
- Minimum investment: $10K
- Investors: 19
- Date of first sale: 2023-02-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-473497
Issuer
- Name: NexEos Diagnostics, Inc.
- CIK: 0001783828
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 11 KYLE DRIVE, CHESTER SPRINGS, PA, 19426
- Phone: 610-203-2379
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Dennis Langer | Director | Naples, FL |
| Christopher Molineaux | Director | Wynnewood, PA |
| Louis Manzi | Director | Delanco, NJ |
| Jeff Himawan | Director | South San Francisco, CA |
| Nicholas Siciliano | Director | Marlton, NJ |
| Stephen Tullman | Director | Malvern, PA |
| Stephen Tullman | Executive Officer | Malvern, PA |
| Nicholas Sicilano | Director | Marlton, NJ |
| Theresa Mansi | Director | Valley Forge, PA |
| Theresa Mansi | Executive Officer | Valley Forge, PA |
| Jeffrey Himawan | Director | San Jose, CA |
Other filings by this issuer (4)
More